ICU Medical Inc (NASDAQ: ICUI) has reported earnings for its third fiscal quarter (ending September 30) of $0.30 versus a loss $-0.55 for the same period a year ago. This result fell short of the consensus estimate of $1.38 by $-1.09. E.P.S. were $-1.17 for the latest four quarters through September 30 versus $-1.53 for the same period a year ago.
Recent Price Action
ICU Medical Inc (NASDAQ: ICUI) stock closed at $102.00 on 11/6/23 after a modest decline of -0.6%. The stock has risen 2.4% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, ICUI is expected to continue to be a modest Value Builder.
ICU Medical has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. ICU Medical has a slightly positive Appreciation Score of 64 but a very low Power Rating of 10, leading to the Negative Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment